[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586888":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":31,"collaborators":7,"id":33,"slug":34,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":37,"acronym":38,"eligibilityCriteria":39,"healthyVolunteers":35,"sex":40,"minAge":41,"maxAge":7,"enrollmentInfo":42,"targetDuration":7,"studyType":45,"phases":7,"briefSummary":46,"conditions":47,"keywords":50,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"Centre Hospitalier Universitaire, Amiens","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Nicolas GUILLAUME, Pr","CONTACT","33+322087046","guillaume.nicolas@chu-amiens.fr",[15],{"facility":16,"status":17,"city":18,"state":7,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"CHRU Amiens","RECRUITING","Amiens","80054","France","FR",{"type":23,"coordinates":24},"Point",[25,26],2.3,49.9,{"lat":26,"lon":25},[29],{"name":30,"role":11,"phone":12,"phoneExt":7,"email":13},"Nicolas Guillaume, Pr",{"type":32,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100586888","hla-antibodies-in-systemic-lupus-erythematosus-100586888",false,"NCT06921239","HLA Antibodies in Systemic Lupus Erythematosus","LEDHLA","Inclusion Criteria:\n\n* Patients Adults\n* Followed in the internal medicine department of Amiens University Hospital - With systemic lupus erythematosus\n* Without HLA immunization risk factors (no history of pregnancy, transfusions or transplants)\n* With sera stored in the biobank\n\nExclusion Criteria:\n\n* minor Patients\n* Opposing the re-use of their personal data for research purposes","ALL","18 Years",{"count":43,"type":44},30,"ESTIMATED","OBSERVATIONAL","Patients suffering from autoimmune diseases show false-positive results when anti-HLA antibodies are identified. This false positivity makes it difficult to obtain an organ transplant based on immunological compatibility (absence of anti-HLA antibodies directed against graft antigens). The objectives of this project are to study the prevalence of these false positivities in a population of lupus patients, and to evaluate biological tests that can negate these false positivities.",[48,49],"HLA Antibodies","Systemic Lupus Erythematosus",[51,52],"HLA antibodies","systemic lupus erythematosus","2026-01-15",{"date":55,"type":56},"2026-01-16","ACTUAL",{"date":58,"type":56},"2025-02-10",{"date":60,"type":44},"2027-05",{"name":5,"class":6},1]